Pages that link to "Q41419934"
Jump to navigation
Jump to search
The following pages link to Guidelines for the use and performance of quantitative outcome measures in ALS clinical trials (Q41419934):
Displaying 19 items.
- Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology committee on Research (Q33762409) (← links)
- Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population (Q36143045) (← links)
- Open label study to assess the safety of VM202 in subjects with amyotrophic lateral sclerosis (Q38760817) (← links)
- Disease progression in amyotrophic lateral sclerosis: predictors of survival (Q40642209) (← links)
- Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy (Q45754303) (← links)
- Sequential designs for clinical trials in amyotrophic lateral sclerosis (Q46412061) (← links)
- Region-specific impairment of the cervical spinal cord (SC) in amyotrophic lateral sclerosis: A preliminary study using SC templates and quantitative MRI (diffusion tensor imaging/inhomogeneous magnetization transfer). (Q48323658) (← links)
- Nocturnal hypoxia in motor neuron disease is not predicted by standard respiratory function tests. (Q48497041) (← links)
- A2A adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients (Q50989087) (← links)
- Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients (Q51066498) (← links)
- Developing normalized strength scores for neuromuscular research (Q51298322) (← links)
- Quality control of vital capacity as a primary outcome measure during phase III therapeutic clinical trial in amyotrophic lateral sclerosis (Q51717478) (← links)
- Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial. (Q52673338) (← links)
- [Functional rating scales for amyotrophic lateral sclerosis] (Q54315826) (← links)
- Maximum voluntary isometric contraction: Reference values and clinical application (Q58206228) (← links)
- Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS) (Q58750007) (← links)
- Quantitative muscle ultrasonography in amyotrophic lateral sclerosis (Q81506833) (← links)
- Amyotrophic lateral sclerosis: early predictors of prolonged survival (Q83988720) (← links)
- Changes in tongue pressure, pulmonary function, and salivary flow in patients with amyotrophic lateral sclerosis (Q85655722) (← links)